Skip to main content
Clinical Trials/NCT03675113
NCT03675113
Withdrawn
Not Applicable

Effects of Upper Extremity Aerobic Exercise Training on Exercise Capacity and Physical Activity Level in Patients With Chronic Heart Failure

Gazi University2 sites in 1 countrySeptember 5, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Heart Failure
Sponsor
Gazi University
Locations
2
Primary Endpoint
Maximal exercise capacity
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

Heart failure is a cardiac structural or functional disorder that, despite normal filling pressures, leads to inability to deliver enough oxygen to meet the metabolic needs o tissue. Heart failure is a serious chronic condition that affects a large proportion of the adult population in the world causing high mortality, leading to exercise intolerance and reduced health-related quality of life. Patients included in the cardiac rehabilitation program slow down disease progression, hospitalization decreases, quality of life improves and health expenditures decrease. Despite the frequent use of upper extremities in daily living activities, studies investigating the effect of upper extremity aerobic training on daily living activities, functional exercise capacity and other outcomes are limited. No studies have investigated the effect of upper extremity aerobic exercise training on physical activity level, functional and maximal exercise capacity and other measures in patients with heart failure.

Detailed Description

It has been reported that exercise capacity in peak arm exercise is almost 30% lower in heart failure patients. For this reason intolerance to arm exercise is a significant problem in heart failure patients and may contribute to a decrease in performance in activities of daily living. Considering the fact that developments in these patients are caused by vasculature functional adaptation the extremity skeletal muscle and applied limbs, upper extremity exercises may be useful to reduce exercise intolerance during activities requiring continuous arm movement.

Registry
clinicaltrials.gov
Start Date
September 5, 2018
End Date
December 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Meral Boşnak Güçlü

associate professor

Gazi University

Eligibility Criteria

Inclusion Criteria

  • Patients with a diagnosis of chronic heart failure diagnosed at rest below 40% of the left ventricular ejection fraction and class 1-3 according to the New York Heart Association classification
  • Optimal medical treatment at least 30 days and clinically stable

Exclusion Criteria

  • Patients with unstable angina pectoris
  • Decompensated heart failure
  • Primary pulmonary hypertension
  • Complex ventricular arrhythmia
  • Contraindication to cardiopulmonary exercise testing
  • Patients who have had myocardial ischemia in the past 3 months
  • Ischemic cerebrovascular events
  • Second and third degree atrioventricular block
  • Thrombus detected in the left ventricle
  • Uncontrolled insulin dependent diabetes mellitus

Outcomes

Primary Outcomes

Maximal exercise capacity

Time Frame: Second day

It will be evaluated using symptom limited cardiopulmonary exercise testing. The cardiopulmonary exercise test will be performed at a progressively increasing speed and grade

Secondary Outcomes

  • Quality of sleep(Second day)
  • Grip strength(First day)
  • Physical activity level(First day)
  • Fatigue(Second day)
  • Anxiety and depression(Second day)
  • Quality of life scale(Second day)
  • Pulmonary function(First day)
  • Respiratory muscle strength(First day)
  • Functional exercise capacity(First day)
  • Pulmonary muscle endurance(First day)
  • Peripheral muscle strength(First day)
  • Activity daily of living(Second day)
  • Dyspnea(Second day)
  • Functional impairment due to dyspnea(First day)

Study Sites (2)

Loading locations...

Similar Trials